Pancreatic Cancer Research

ResearcherInstituto Carlos ChagasActive in the last 2 years

Mateus Nóbrega Aoki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-5166-2897; OpenAlex author ID A5059245767. Sources: OpenAlex.

Their work

Papers
19 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2021: 3 papers · 2022: 2 papers · 2023: 7 papers · 2024: 2 papers · 2025: 3 papers · 2026: 2 papers

Papers 19

  1. Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing. Last author DOI 10.1038/s41598-026-42403-4↗
  2. miRNA484 and miRNA335-5p as Potential Diagnostic Biomarkers for CA19-9-Negative Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/biom16081160↗
  3. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  4. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.02.009↗
  5. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  6. Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. Co-author DOI 10.1002/ijc.35046↗
  7. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  8. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  9. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  10. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarc… Co-author DOI 10.1093/carcin/bgad056↗
  11. Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
  12. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  13. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. Last author DOI 10.3390/biomedicines11041069↗
  14. Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. Last author DOI 10.3390/ijms241612604↗
  15. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. Co-author DOI 10.1038/s41598-022-22973-9↗
  16. Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients. Last author DOI 10.3390/biom12060769↗
  17. Susceptibility loci for pancreatic cancer in the Brazilian population. Co-author DOI 10.1186/s12920-021-00956-5↗
  18. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  19. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Co-author DOI 10.3389/fonc.2021.771312↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anelis Maria Marin · 6 shared papers, 2021–2026 · strength 1.27
  2. Federico Canzian · 3 shared papers, 2021–2026 · strength 0.51
  3. Guilherme Naccache Namur · 2 shared papers, 2023–2026 · strength 0.49
  4. Nayra Oliveira Prado · 1 shared paper, 2026 · strength 0.29
  5. Giulia Peduzzi · 2 shared papers, 2022–2025 · strength 0.27
  6. Daniele Campa · 2 shared papers, 2022–2025 · strength 0.27
  7. Manuel Gentiluomo · 2 shared papers, 2022–2025 · strength 0.27
  8. Bhavana Hemantha Rao · 1 shared paper, 2025 · strength 0.17
  9. Lucy S. Oldfield · 1 shared paper, 2025 · strength 0.17
  10. Caoimhe M. Walsh · 1 shared paper, 2025 · strength 0.17
  11. Irena Stefanova · 1 shared paper, 2025 · strength 0.17
  12. Robert Van Der Meer · 1 shared paper, 2025 · strength 0.17
  13. Andrei Turtoï · 1 shared paper, 2025 · strength 0.17
  14. Kate Murray · 1 shared paper, 2025 · strength 0.17
  15. William Greenhalf · 1 shared paper, 2025 · strength 0.17
  16. George Bushra Hanna · 1 shared paper, 2025 · strength 0.17
  17. Salvatore Paiella · 1 shared paper, 2025 · strength 0.17
  18. Pinar Uysal Onganer · 1 shared paper, 2025 · strength 0.17
  19. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.17
  20. Eithne Costello · 1 shared paper, 2025 · strength 0.17
  21. Giovanni Luigi Capretti · 1 shared paper, 2022 · strength 0.10
  22. Sabrina Gloria Giulia Testoni · 1 shared paper, 2022 · strength 0.10
  23. Maria Gazouli · 1 shared paper, 2022 · strength 0.10
  24. Verena Andrea Katzke · 1 shared paper, 2022 · strength 0.10
  25. Caterina Stornello · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.